FDA Clearance Tracker · P150001
MINIMED 630G SYSTEM WITH SMARTGUARD(TM)
Last checked: Nov 19, 2026Latest source record: Aug 10, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Aug 10, 2016
Approved
Time to decision
580 days
Received Jan 8, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P150001
- Device name
- MINIMED 630G SYSTEM WITH SMARTGUARD(TM)
- Applicant
- Medtronic Minimed
- Applicant location
- Northridge, CA
- Received
- Jan 8, 2015
- Decided
- Aug 10, 2016
- Decision
- Approved
- Supplements
- 100 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the MiniMed 630G System with SmartGuard.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OZO. The earliest in FDA's data is P120010, decided Sep 26, 2013.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medtronic Minimed
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261962 · Decided Jul 9, 2026 · 28 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
- MiniMed Flex pump510(k)
K253743 · Decided Mar 12, 2026 · 108 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
K253701 · Decided Feb 3, 2026 · 71 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.